INTERVENTIONAL FLASHLIGHT

DOI: 10.4244/EIJ-D-17-00824

Recovery of absolute coronary flow and resistance one week after percutaneous coronary intervention of a chronic totally occluded coronary artery using the novel RayFlow© infusion catheter

Daniëlle C.J. Keulards*, MD; Frederik M. Zimmermann, MD; Nico H.J. Pijls, MD, PhD; Koen Teeuwen, MD

A 59-year-old male was admitted to the Catharina Hospital with unstable angina. Coronary angiography showed a chronic total occlusion (CTO) of the right coronary artery (RCA) (Panel A), and a proximal subtotal stenosis of the ramus circumflex (RCx) and septal collaterals (Rentrop grade 1) from the left anterior descending (LAD) to the RCA (Panel D). After discussion in the Heart Team, we decided not to perform percutaneous coronary intervention (PCI) of the LAD due to diffuse disease, discovered during the hyperaemic pullback, and the patient was scheduled for PCI of the chronic occluded RCA. Using the new technique of thermodilution with a low rate of saline (RayFlow© infusion catheter [Hexacath Inc., Paris, France], and CoroFlow™ software [Coroventis, Uppsala, Sweden]), we measured absolute flow and resistance in the donor vessel (the LAD) before and after PCI of the CTO (Panel D, Panel E)1,2. Absolute flow in the LAD before PCI of the RCA was 256 ml/min, with a microvascular resistance of 231 Wood units (WU). Additionally, we measured flow and resistance in the RCA after successful treatment, being 161 ml/min and 370 WU, respectively (Panel B, Panel G). Staged PCI of the RCx was performed after one week and all measurements in the RCA and LAD were repeated (Panel C, Panel F, Panel H). The absolute flow in the RCA had increased now by 86% to 300 ml/min compared to one week previously, with a decrease in microvascular resistance of 33% to 243 WU. Blood flow in the LAD area had decreased to 215 ml/min, due to the decrease of perfusion territory (Panel F).

This case elegantly demonstrates how this method can be used in the cath lab to study recovery of flow after PCI of a CTO. It illustrates that the microvasculature distal to a CTO needs a number of days to recover and normalise.

Conflict of interest statement

The authors have no conflicts of interest to declare.

Volume 14 Number 5
Aug 3, 2018
Volume 14 Number 5
View full issue


Key metrics

Suggested by Cory

Clinical research

10.4244/EIJ-D-22-00118 Dec 2, 2022
Changes in coronary collateral function after successful chronic total occlusion percutaneous coronary intervention
Keulards D et al
free

Clinical Research

10.4244/EIJ-D-21-00702 Jul 22, 2022
Impact of percutaneous coronary intervention of chronic total occlusions on absolute perfusion in remote myocardium
de Winter R et al
free

Image – Interventional flashlight

10.4244/EIJ-D-19-00973 Apr 2, 2021
Relationship between fractional flow reserve value and the amount of subtended myocardium
Tsujimoto M et al
free

Editorial

10.4244/EIJ-E-22-00016 Jul 22, 2022
The myocardial perfusion paradigm: a missing link between patient selection and appropriateness of treatment
Mashayekhi K and Pyxaras S
free
Trending articles
151.43

State-of-the-Art

10.4244/EIJ-D-22-00776 Apr 3, 2023
Computed tomographic angiography in coronary artery disease
Serruys PW et al
free
55.9

Clinical research

10.4244/EIJ-D-22-00621 Feb 20, 2023
Long-term changes in coronary physiology after aortic valve replacement
Sabbah M et al
free
54.9

Expert review

10.4244/EIJ-D-21-01010 Jun 24, 2022
Device-related thrombus following left atrial appendage occlusion
Simard T et al
free
43.75

Clinical Research

10.4244/EIJ-D-21-01091 Aug 5, 2022
Lifetime management of patients with symptomatic severe aortic stenosis: a computed tomography simulation study
Medranda G et al
free
39.95

Clinical research

10.4244/EIJ-D-22-00558 Feb 6, 2023
Permanent pacemaker implantation and left bundle branch block with self-expanding valves – a SCOPE 2 subanalysis
Pellegrini C et al
free
X

The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)

EuroPCR EAPCI
PCR ESC
Impact factor: 7.6
2023 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2024)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2024 Europa Group - All rights reserved